AlphAIAlphAI — Financial news for AI agents
finance.yahoo.com$HUM

Humana Inc. Q3 2026 Earnings Call Summary

Humana Inc. raised its 2026 adjusted EPS outlook due to strong operational performance and medical cost trends. The company is focusing on top quartile Star ratings and expects 2027 membership growth. A joint venture with BlackRock aims to improve balance sheet efficiency. Humana anticipates a 3%+ individual MA margin by 2028, with 2027 showing progress. The divestment of Gentiva is expected to close in Q4 2026, providing $900 million in pretax proceeds.

Original reporting
finance.yahoo.com
Published Nov 6, 2026, 6:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 7:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Humana Inc. Q3 2026 Earnings Call Summary — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$HUMBullishMed
01

Why it matters

The combination of higher EPS guidance, debt reduction, and cash proceeds creates a favorable outlook for the stock.

02

Market read

Humana's updated guidance and balance‑sheet actions are likely to move the stock positively in after‑hours trading.

03

What to watch

Potential regulatory changes to Medicare Advantage could affect margin assumptions.

Relevance 8/10Novelty 7/10Timing: after-hours reaction

Background

Humana's earnings call covered operational execution, cost trends, a new BlackRock JV, and a planned divestiture.

Company-level read

Ticker impact

$HUMBullishHigh confidence
Context

Humana raised its 2026 adjusted EPS outlook and announced a $900M divestiture of its minority interest in Gentiva, plus a BlackRock joint venture to cut debt.

Expected impact

likely upward pressure as the market prices in higher earnings guidance and debt reduction.

Evidence & confidence

The EPS outlook raise and $900M proceeds are material new information that can improve margins and balance sheet strength.

Market effects

Sector

Health insurance sector may see modest rating upgrades as Humana's margin outlook improves.

Regional

U.S. healthcare stocks could experience slight gains in the near term.

Global

Limited to U.S. markets; no direct global impact.

Counterpoint

What could challenge this read

If the cost trend for Part D accelerates faster than expected, the guidance lift could be overstated.

Key entities

  • company
    Humana Inc.

    U.S. health insurance provider.

  • company
    BlackRock

    Asset manager partnering with Humana in a joint venture.

Read at source← All news

StoryHumana reports third-quarter loss and raises 2026 adjusted EPS guidance

Also covered by

6 outlets

Related articles

$HUMHighAI 8/10

Humana 3Q 2026: Revenue $41.16B, EPS $1.33 — 10-Q Summary

Humana reported 3Q 2026 revenue of $41.16B, up 26.1% YoY, driven by Medicare membership growth and higher premiums. Net income fell 16.9% to $162M, with EPS at $1.33. Insurance membership grew 20.3%, but the segment saw a $303M operating loss. CenterWell revenue rose 40.4% to $1.9B, though costs increased.

tradingview.com
$HUMHighAI 8/10

Humana (HUM) Q3 2026 Earnings Call Transcript

Humana (HUM) reported Q3 2026 earnings with adjusted EPS of $17.17 YTD and a Q3 loss of $0.70, down from $3.24 YoY. Full-year adjusted EPS guidance raised to at least $9.50. GAAP EPS for Q3 was $1.33, down from $1.62 in 2025. The company expects $900M in pretax proceeds from Gentiva divestment. Medicare Advantage enrollment and Star ratings improved, but Part D cost trends are expected to rise to 14-15% in 2027.

fool.com
$HUMHighAI 8/10

Humana Raises Profit Floor on Lower Costs

Humana (HUM) raised its 2026 adjusted earnings guidance to at least $9.50 per share from $9.00, citing lower costs. Q3 insurance benefit ratio was 93.7%, better than expected. Shares fell 0.59% in pre-market trading. Humana's Medicare Advantage membership grew 23% this year.

asktraders.com
$HUMHighAI 8/10

HUM Q3 FY2026 earnings call

Humana Inc. reported Q3 2026 earnings exceeding expectations, raising full-year adjusted EPS guidance to at least $9.50. The company cited favorable medical cost trends and strong execution. Management highlighted progress in clinical quality, Medicaid expansion, and capital allocation, including a divestiture and a new joint venture. Humana expects 2027 Medicare Advantage membership growth and an 8%-9% medical cost trend, with risks and opportunities outlined.

finance.biggo.com